Insulet reports 21% sales growth in Q1, raises 2023 guidance
Insulet (Nasdaq:PODD) shares ticked up after hours today on first-quarter results that topped the consensus forecast.
Stay updated with breaking news from Massdevice Medtech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet (Nasdaq:PODD) shares ticked up after hours today on first-quarter results that topped the consensus forecast.
Insulet shares are up on first-quarter results that topped the consensus forecast.
LivaNova (Nasdaq:LIVN) shares dipped this morning on first-quarter results that topped the consensus forecast.
Avanos Medical (NYSE:AVNS) posted first-quarter results that aligned with the earnings consensus on Wall Street but missed revenue estimates.
Tandem Diabetes Care (Nasdaq:TNDM) shares ticked down after hours today on first-quarter results that fell shy of the consensus forecast.